The PainChek (ASX:PCK) share price is rising on its latest announcement

Shares in PainChek Ltd are gaining today after the company has received regulatory clearances for its app, PainChek Infant.
The post The PainChek (ASX:PCK) share price is rising on its latest announcement appeared first on The Motley Fool Australia. –

Shares in PainChek Ltd (ASX: PCK) are gaining today after news the company has received regulatory clearances for its app, PainChek Infant. At the time of writing, the PainChek share price is up 6.15%, with shares in the company swapping hands for 6.9 cents apiece.

As a result of the clearances, PainChek can market its pain sensing app for babies in Australia, Europe, the United Kingdom, Canada, Singapore, and New Zealand.

PainChek also announced its successful Infant Face-Only study is being peer-reviewed for publication. The study determined the app could successfully analyse a baby’s facial expressions and evaluate if they’re in pain.

Let’s take a closer look at the latest news from Painchek.  

PainChek Infant

Painchek has announced that it’s received a number of regulatory approvals needed market its PainChek Infant app.

The company now plans to launch its infant app in a number of countries. It will focus particularly on the hospital and home care markets.

PainChek says that its app can help healthcare professionals, parents, and carers to evaluate if a non-verbal child is in pain. Additionally, the app will help gauge how much pain the child is in.

According to PainChek, there are around 400 million pre-verbal children globally. Moreover, one quarter is born to first-time parents. Furthermore, PainChek stated this gives it a large market entry point.

The company also said that, while clinicians have access to paper-based pain measuring tools for infants, they are rarely used. Additionally, it claimed that high levels of exposure to pained infants can sometimes lead to medical professionals dismissing babies’ pain signals.

PainChek plans to continue expanding its app’s abilities. Currently, it is working to broaden the age range of children whose pain can be assessed. It will do so by conducting further research and clinical studies. It is also currently conducting a study at Melbourne’s Royal Children’s Hospital.

PainChek already has an app available that uses facial expressions to sense pain in non-verbal adults.

Commentary from management

PainChek’s CEO Philip Daffas commented on the PainChek Infant app’s approval, saying:

We’re delighted to achieve this regulatory milestone ahead of schedule and continue to expand PainChek’s global markets. The PainChek Infant App is unique in that it completes a microfacial analysis through a 3 second video assessment and provides the carer with an instant result in relation to the infant’s pain severity level…

Having established the initial PainChek Adult App and the business model in aged care, this broad portfolio of offerings provides the foundation for our global market entry into the larger home care and the hospital markets.

PainChek share price snapshot

The PainChek share price needs the good news as it battles a tough 2021 on the ASX.

Currently, the PainChek share price is down 12.5% year to date. It’s also fallen 56% since this time last year.

The company has a market capitalisation of around $73 million, with approximately 1.1 billion shares outstanding.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

*Returns as of February 15th 2021

More reading

Lower ASX 200 shares? The ground is moving on interest rates

Is the Afterpay (ASX:APT) share price cheap? Here’s what 1 broker thinks
Why the Advanced Human Imaging (ASX:AHI) share price is jumping 15%
Estrella (ASX:ESR) share price is exploding today, up 17%. Here’s why
Why Flight Centre, Iluka, Nuix, & Oil Search shares are tumbling lower

The post The PainChek (ASX:PCK) share price is rising on its latest announcement appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!